|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 170.68 USD | +3.06% |
|
+9.38% | +39.06% |
| 10-30 | Gilead's HIV Franchise Supports Growth Outlook, RBC Says | MT |
| 10-30 | UBS Adjusts Gilead Sciences Price Target to $195 From $175, Maintains Buy Rating | MT |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Static Chart
Select your edition
All financial news and data tailored to specific country editions
